TIP60 inhibits metastasis by ablating DNMT1-SNAIL2-driven epithelial-mesenchymal transition program

Yanzhou Zhang1, Vanitha Krishna Subbaiah1, Deepa Rajagopalan1,2

  • 1Cancer Science Institute of Singapore, National University of Singapore, Singapore.

Insights

HIV-Tat-interacting protein of 60 kDa (TIP60) downregulation promotes breast cancer metastasis by stabilizing DNMT1 and increasing SNAIL2. Restoring TIP60 may offer a novel cancer treatment strategy.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Epigenetics

Background:

  • HIV-Tat-interacting protein of 60 kDa (TIP60) is a lysine acetyltransferase implicated in cancer.
  • TIP60 plays a role in regulating epithelial-mesenchymal transition (EMT), a process crucial for cancer metastasis.

Purpose of the Study:

  • To investigate the role of TIP60 in breast cancer cell migration and metastasis.
  • To elucidate the molecular mechanisms by which TIP60 affects EMT and cancer progression.

Main Methods:

  • In vitro and in vivo models of breast cancer were utilized.
  • Investigated the interaction between TIP60, DNMT1, and SNAIL2.
  • Analyzed DNA methylation patterns and gene expression of epithelial markers.

Main Results:

  • TIP60 expression inhibited breast cancer cell migration and metastasis.
  • TIP60 destabilizes DNMT1 and inhibits SNAIL2, thereby suppressing EMT.
  • TIP60 depletion leads to DNMT1 stabilization, increased SNAIL2, and enhanced EMT.
  • DNMT1 recruitment to SNAIL2 targets in TIP60-depleted cells increases DNA methylation and represses epithelial markers.
  • Low TIP60 levels correlate with poor survival in breast cancer patients.

Conclusions:

  • TIP60 functions as a suppressor of breast cancer cell migration and metastasis.
  • TIP60 regulates EMT via the DNMT1/SNAIL2 axis.
  • TIP60 downregulation is associated with poor prognosis in breast cancer patients.
  • TIP60 levels may serve as a prognostic marker, and TIP60 stabilization is a potential therapeutic strategy.